Aura Biosciences is an innovation-driven company focused on the development of drugs using tumor targeted Viral-like Nanoparticles, breakthrough technology discovered and patented by Dr. John Schiller at the National Cancer Institute (NCI). This is a novel approach that harnesses the power of synthetic biology and viral evolution.
Aura has been granted Orphan Disease Designation by the FDA for the drug AU-011 for the treatment of Ocular Melanoma. Click the icon below to see a representation of the mechanism of action of AU-011 in Ocular Melanoma.
Click Video to Begin Playback.